Shouresh DDS - ProSomnus, Common Global Chair
| OSADelisted Stock | 0.47 0.00 0.00% |
Insider
Shouresh DDS is Global Chair of ProSomnus, Common Stock
| Phone | 844 537 5337 |
| Web | https://www.prosomnus.com |
ProSomnus, Common Management Efficiency
The company has Return on Asset of (0.4015) % which means that on every $100 spent on assets, it lost $0.4015. This is way below average. ProSomnus, Common's management efficiency ratios could be used to measure how well ProSomnus, Common manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Matthew Getz | Artivion | 55 | |
| John Treace | Treace Medical Concepts | 52 | |
| Thomas Ackerman | Artivion | 66 | |
| Jared Oasheim | CVRx Inc | 41 | |
| Andre Marquette | Neuropace | N/A | |
| Heather Brennan | Establishment Labs Holdings | N/A | |
| Barbara Schwarzentraub | CONMED | 53 | |
| Marco Dolci | LivaNova PLC | 62 | |
| Margaret Carthy | Integer Holdings Corp | 60 | |
| Andrew Green | Artivion | 52 | |
| Anthony Semedo | Artivion | 69 | |
| Shanna Cottiosmanski | CONMED | 47 | |
| Lindsey Little | LivaNova PLC | N/A | |
| Elizabeth Giddens | Integer Holdings Corp | 49 | |
| Daniel Bevevino | Artivion | 61 | |
| Mark Saxton | Neuropace | 59 | |
| Martha Morrell | Neuropace | 67 | |
| Jean Holloway | Artivion | 63 | |
| Geoffrey Rose | Pulmonx Corp | 50 | |
| Michael Favet | Neuropace | 54 | |
| Ehab Esmail | Orthofix Medical | 52 | |
Management Performance
| Return On Asset | -0.4 |
ProSomnus, Common Stock Leadership Team
Elected by the shareholders, the ProSomnus, Common's board of directors comprises two types of representatives: ProSomnus, Common inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ProSomnus,. The board's role is to monitor ProSomnus, Common's management team and ensure that shareholders' interests are well served. ProSomnus, Common's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ProSomnus, Common's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sung Kim, CoFounder CTO | ||
| Mindy Hungerman, Chief Officer | ||
| Jerry Vogel, VP Sales | ||
| Heather Whalen, VP Communications | ||
| Len Liptak, CEO CoFounder | ||
| Shouresh DDS, Global Chair | ||
| Leonard Liptak, CEO CoFounder | ||
| Laing Rikkers, Cofounder Chairman | ||
| Brian Dow, Chief Officer | ||
| John MD, Chief Scientist |
ProSomnus, Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ProSomnus, Common a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.4 | |||
| Profit Margin | (0.87) % | |||
| Operating Margin | (0.64) % | |||
| Current Valuation | 16.13 M | |||
| Shares Outstanding | 17.39 M | |||
| Shares Owned By Insiders | 20.63 % | |||
| Shares Owned By Institutions | 57.01 % | |||
| Number Of Shares Shorted | 73.91 K | |||
| Price To Sales | 0.30 X | |||
| Revenue | 27.65 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in ProSomnus, Stock
If you are still planning to invest in ProSomnus, Common Stock check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ProSomnus, Common's history and understand the potential risks before investing.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |